Likewise, Thor et al [24], Quddus et al [13] and Wang et al [25] have documented that HER2 (+) tumor cells are more likely to be eliminated by chemotherapy, and patients with a high percentage of HER2-positive tumor cells showed a good pathologic response. The gene discussed is ERBB2; the disease is neoplasm.